Reference number : 172-2018-2019-Q3-916018, amendment number : , agreement type : C, recipient legal name : Kisoji Biotechnologie Inc., recipient country : CA, recipient province : QC, recipient city : Laval|Laval, recipient postal code : H7V 3S8, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Development of novel single domain antibodies for cancer therapy II, agreement title french : Développement de nouveaux anticorps à un seul domaine pour le traitement du cancer II, agreement number : 916018, agreement value : 350000.0, agreement start date : 2018-11-01, agreement end date : 2019-11-01, description english : Cancer remains a very important disease in North America and the world. Antibodies have emerged as an effective treatment for cancer. KisoJi is developing antibodies for treatment of newly diagnosed cancers and for previously treated cancers., description french : Développement de nouveaux anticorps à un seul domaine pour le traitement du cancer II, expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada